Search for persons
X
?
1
Inflammation, Hyperglycemia, and Adverse Outcomes in Indivi..:
Alexi Vasbinder (11868077) ; Elizabeth Anderson (20931) ; Husam Shadid (11868080)...
https://figshare.com/articles/figure/Inflammation_Hyperglycemia_and_Adverse_Outcomes_in_Individuals_With_Diabetes_Mellitus_Hospitalized_for_COVID-19/17383496. , 2022
https://figshare.com/articles/figure/Inflammation_Hyperglycemia_and_Adverse_Outcomes_in_Individuals_With_Diabetes_Mellitus_Hospitalized_for_COVID-19/17383496. , 2022
?
2
The ICU patients' visceral and subcutaneous adipose tissue ..:
Theresa H. Wirtz (9406424) ; Sven H. Loosen (5866946) ; Maximilian Schulze-Hagen (10508615)...
https://figshare.com/articles/figure/The_ICU_patients_visceral_and_subcutaneous_adipose_tissue_areas_correlate_with_BMI_and_differ_between_the_genders_/14440830. , 2021
https://figshare.com/articles/figure/The_ICU_patients_visceral_and_subcutaneous_adipose_tissue_areas_correlate_with_BMI_and_differ_between_the_genders_/14440830. , 2021
?
3
Elevated baseline median particle size predicts an unfavora..:
David Schöler (11292816) ; Mirco Castoldi (47117) ; Markus S. Jördens (5906504)...
https://figshare.com/articles/figure/Elevated_baseline_median_particle_size_predicts_an_unfavorable_outcome_after_TACE_/15213309. , 2021
https://figshare.com/articles/figure/Elevated_baseline_median_particle_size_predicts_an_unfavorable_outcome_after_TACE_/15213309. , 2021
?
4
Image_3_Serum Levels of Soluble Urokinase Plasminogen Activ..:
Sven H. Loosen (5866946) ; Joao Gorgulho (10508612) ; Markus S. Jördens (5906504)...
https://figshare.com/articles/figure/Image_3_Serum_Levels_of_Soluble_Urokinase_Plasminogen_Activator_Receptor_Predict_Tumor_Response_and_Outcome_to_Immune_Checkpoint_Inhibitor_Therapy_tiff/14350667. , 2021
https://figshare.com/articles/figure/Image_3_Serum_Levels_of_Soluble_Urokinase_Plasminogen_Activator_Receptor_Predict_Tumor_Response_and_Outcome_to_Immune_Checkpoint_Inhibitor_Therapy_tiff/14350667. , 2021
?
5
MiRNA-107 expression levels in HCC tissue represent a progn..:
Sven H. Loosen (5866946) ; Mirco Castoldi (47117) ; Markus S. Jördens (5906504)...
https://figshare.com/articles/figure/MiRNA-107_expression_levels_in_HCC_tissue_represent_a_prognostic_marker_/14209142. , 2021
https://figshare.com/articles/figure/MiRNA-107_expression_levels_in_HCC_tissue_represent_a_prognostic_marker_/14209142. , 2021
?
6
Serum levels of circulating miR-107 are unsuitable to predi..:
Sven H. Loosen (5866946) ; Mirco Castoldi (47117) ; Markus S. Jördens (5906504)...
https://figshare.com/articles/figure/Serum_levels_of_circulating_miR-107_are_unsuitable_to_predict_outcome_in_early-stage_HCC_patients_/14209151. , 2021
https://figshare.com/articles/figure/Serum_levels_of_circulating_miR-107_are_unsuitable_to_predict_outcome_in_early-stage_HCC_patients_/14209151. , 2021
?
7
Association between achalasia and depression in patients fo..:
Sven H. Loosen (5866946) ; Jennis Kandler (10297097) ; Tom Luedde (180139)..
https://figshare.com/articles/dataset/Association_between_achalasia_and_depression_in_patients_followed_in_general_practices_in_the_Germany_/14521489. , 2021
https://figshare.com/articles/dataset/Association_between_achalasia_and_depression_in_patients_followed_in_general_practices_in_the_Germany_/14521489. , 2021
?
8
Baseline patient characteristics at the time point of admis..:
Theresa H. Wirtz (9406424) ; Sven H. Loosen (5866946) ; Maximilian Schulze-Hagen (10508615)...
https://figshare.com/articles/dataset/Baseline_patient_characteristics_at_the_time_point_of_admission_and_mean_visceral_and_subcutaneous_adipose_tissue_areas_/14440848. , 2021
https://figshare.com/articles/dataset/Baseline_patient_characteristics_at_the_time_point_of_admission_and_mean_visceral_and_subcutaneous_adipose_tissue_areas_/14440848. , 2021
?
9
Characteristics of visceral and subcutaneous adipose tissue..:
Theresa H. Wirtz (9406424) ; Sven H. Loosen (5866946) ; Maximilian Schulze-Hagen (10508615)...
https://figshare.com/articles/figure/Characteristics_of_visceral_and_subcutaneous_adipose_tissue_area_in_ICU_patients_with_various_comorbidities_/14440836. , 2021
https://figshare.com/articles/figure/Characteristics_of_visceral_and_subcutaneous_adipose_tissue_area_in_ICU_patients_with_various_comorbidities_/14440836. , 2021
?
10
Serum levels of various laboratory markers:
Sven H. Loosen (5866946) ; Mirco Castoldi (47117) ; Markus S. Jördens (5906504)...
https://figshare.com/articles/dataset/Serum_levels_of_various_laboratory_markers_/14209157. , 2021
https://figshare.com/articles/dataset/Serum_levels_of_various_laboratory_markers_/14209157. , 2021
?
11
Neither the VAT nor SAT area predicts short-term survival i..:
Theresa H. Wirtz (9406424) ; Sven H. Loosen (5866946) ; Maximilian Schulze-Hagen (10508615)...
https://figshare.com/articles/figure/Neither_the_VAT_nor_SAT_area_predicts_short-term_survival_in_critically_ill_patients_/14440842. , 2021
https://figshare.com/articles/figure/Neither_the_VAT_nor_SAT_area_predicts_short-term_survival_in_critically_ill_patients_/14440842. , 2021
?
12
Initial median particles size (X50) does not correlate with..:
David Schöler (11292816) ; Mirco Castoldi (47117) ; Markus S. Jördens (5906504)...
https://figshare.com/articles/figure/Initial_median_particles_size_X50_does_not_correlate_with_initial_EVS_concentrations_or_size_of_target_lesion_/15213291. , 2021
https://figshare.com/articles/figure/Initial_median_particles_size_X50_does_not_correlate_with_initial_EVS_concentrations_or_size_of_target_lesion_/15213291. , 2021
?
13
Particle size (X50) and particle concentration do not diffe..:
David Schöler (11292816) ; Mirco Castoldi (47117) ; Markus S. Jördens (5906504)...
https://figshare.com/articles/figure/Particle_size_X50_and_particle_concentration_do_not_differ_in_patients_with_and_without_objective_response_OR_after_TACE_/15213300. , 2021
https://figshare.com/articles/figure/Particle_size_X50_and_particle_concentration_do_not_differ_in_patients_with_and_without_objective_response_OR_after_TACE_/15213300. , 2021
?
14
Assessment of visceral and subcutaneous adipose tissue dist..:
Theresa H. Wirtz (9406424) ; Sven H. Loosen (5866946) ; Maximilian Schulze-Hagen (10508615)...
https://figshare.com/articles/figure/Assessment_of_visceral_and_subcutaneous_adipose_tissue_distribution_/14440827. , 2021
https://figshare.com/articles/figure/Assessment_of_visceral_and_subcutaneous_adipose_tissue_distribution_/14440827. , 2021
?
15
MiRNA-107 levels are upregulated in HCC patients:
Sven H. Loosen (5866946) ; Mirco Castoldi (47117) ; Markus S. Jördens (5906504)...
https://figshare.com/articles/figure/MiRNA-107_levels_are_upregulated_in_HCC_patients_/14209145. , 2021
https://figshare.com/articles/figure/MiRNA-107_levels_are_upregulated_in_HCC_patients_/14209145. , 2021